| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2400484 | 注射用重组人源化抗BCMA/CD3双特异性抗体 | Recombinant Humanized Anti-BCMA/CD3 Bis-specific Antibody Preparation | Lyophilized | Biological Products(1) | New Drug Application | 2024-07-27 | Shandong New Time Pharmaceutical Co Ltd | view | |||
| CXSL2100063 | 注射用重组人源化抗BCMA/CD3双特异性抗体 | Recombinant Humanized Anti-BCMA/CD3 Bis-specific Antibody Preparation | Lyophilized | Biological Products(1) | New Drug Application | 2021-02-27 | 山东新时代药业有限公司 | Shandong New Time Pharmaceutical Co Ltd | In Review | 2021-02-26 | view |